James E. Flynn - Director, Director by deputization, 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, Director by deputization, 10%+ Owner
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 9/16/2023

Holdings reported by James E. Flynn for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.54M $21M $3.78 Nov 8, 2022 Through Deerfield Private Design Fund III, L.P.
Common stock 5.54M $21M $3.78 Nov 8, 2022 Through Deerfield Private Design Fund IV, L.P.

There are no transactions reported by James E. Flynn for ARS Pharmaceuticals, Inc.